ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas L. Spray
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurth, C. D.
Right arrow Articles by Nicolson, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurth, C. D.
Right arrow Articles by Nicolson, S. C.
Related Collections
Right arrow Congenital - cyanotic

Ann Thorac Surg 2001;72:187-192
© 2001 The Society of Thoracic Surgeons


Original article: cardiovascular

Cerebral oxygen saturation before congenital heart surgery

C. Dean Kurth, MDa,c,d,f, James L. Steven, MDa,c,d,f, Lisa M. Montenegro, MDa,d, H. Marc Watzman, MDa,d, J. William Gaynor, MDb,e, Thomas L. Spray, MDb,e, Susan C. Nicolson, MDa,d a Department of Anesthesiology and Critical Care Medicine, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
b Department of Surgery, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
c Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadephia, Pennsylvania, USA
d Department of Anesthesia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
e Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
f Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Accepted for publication March 2, 2001.

Address reprint requests to Dr Kurth, Department of Anesthesiology, The Children’s Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104
e-mail: kurth{at}email.chop.edu


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Background. In congenital heart disease (CHD), neurologic abnormalities suggestive of hypoxia-ischemia are often apparent before cardiac surgery. To evaluate preoperative cerebral oxygenation, this study determined cerebral O2 saturation (ScO2) in CHD and healthy children.

Methods. Ninety-one CHD and 19 healthy children aged less than 7 years were studied before surgical or radiologic procedures. Arterial saturation (SaO2) and ScO2 were measured by pulse-oximetry and near infrared cerebral oximetry. Cerebral O2 extraction (CEO2) was calculated (SaO2-ScO2). SaO2, ScO2, and CEO2 were compared among diagnoses. Multivariable regression was performed between ScO2 and clinical variables.

Results. In healthy subjects, ScO2 (68% ± 10%) and CEO2 (30% ± 11%) were similar to patients with ventricular septal defect, aortic coarctation, and single ventricle after Fontan operation. ScO2 was significantly decreased in patients with patent ductus arteriosus (53% ± 8%), tetralogy of Fallot (57% ± 12%), hypoplastic left heart syndrome (46% ± 8%), pulmonary atresia (38% ± 6%), and single ventricle after aortopulmonary shunt (50% ± 7%), or bidirectional Glenn operation (43% ± 6%). CEO2 was significantly different only in patent ductus arteriosus (46% ± 8%) and hypoplastic left heart syndrome (38% ± 12%). In multivariable regression, only SaO2 was related to ScO2 (R = 0.63, p < 0.001).

Conclusions. Cerebral oxygenation in CHD varies with anatomy and arterial saturation, and in some patients, it is very low compared with healthy subjects.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Advances in the care of children born with congenital heart disease (CHD) over the past decade have yielded a dramatic reduction in mortality. Attention is now being directed to the morbidity associated with the disease and its treatment. Of particular concern are the neurologic problems, which afflict 5 to 25% of the survivors, and include diminished cognitive performance, developmental delay, attention deficit hyperactivity disorder, seizures, and cerebral palsy [13]. Many of these problems have been attributed to cardiopulmonary bypass (CPB), deep hypothermia, and/or total circulatory arrest (DHCA). However, a growing body of evidence indicates that many neurologic abnormalities originate before surgery [36]. The etiology of these abnormalities remains uncertain, although they are suspected in many instances to reflect cerebral hypoxia-ischemia.

Identifying cerebral hypoxia-ischemia in infants with CHD has been difficult. Neurologic examination, electroencephalography, jugular bulb oximetry, and magnetic resonance imaging (MRI) are nonspecific tests or risky procedures to perform in critically ill infants. On the horizon, are noninvasive, bedside, optical technologies such as cerebral oximetry and near infrared spectroscopy (NIRS), which can detect tissue hypoxia-ischemia.

Previous work with NIRS described changes in cerebral oxygenation in neonates, infants, and children undergoing cardiovascular surgery. These studies found cerebral oxygenation to decrease during low flow CPB and DHCA, indicating that certain phases of the surgical procedure put the brain at risk of hypoxic-ischemic injury [710]. However, limitations in the technology precluded the determination of cerebral oxygenation before surgery (ie, base line). The technologic advances in the past few years have permitted the determination of base line cerebral oxygenation and investigation of cerebral hypoxia-ischemia before surgery. The present study examined cerebral O2 saturation (ScO2) in neonates, infants, and children with CHD before surgery.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Subjects
After Institutional Review Board approval and informed parental consent, we enrolled children aged older than 7 years of age scheduled for cardiac surgical or radiologic procedures. Inclusion criteria included the presence of congenital cardiovascular disease (CHD group), or absence of systemic disease (healthy subjects-Control group). Exclusion criteria were pulmonary, neurologic, or craniofacial disease, history of birth asphyxia, or a genetic abnormality associated with a brain malformation.

Studies were conducted in the cardiac operating room before induction of general anesthesia, or in the radiology sedation suite. All subjects aged older than 6 months received sedative medication before the study, according to our institutional practice. The cardiac surgical premedication consisted of pentobarbital (4 mg/kg PO) for infants 6 months to 1 year, and pentobarbital and meperidine (3 mg/kg PO) for children older than 1 year. The radiologic pre-medication was pentobarbital (2 mg/kg IV). Infants aged less than 6 months did not receive sedative medication.

Cerebral oximetry
NIRS and cerebral oximetry are identical technologies. They rely on the relative transparency of biological tissue to near infrared light (700 to 900 nm) where oxy- and deoxy hemoglobin and cytochrome aa3 have distinct absorption spectra. By monitoring light signals at several wavelengths, it is possible to determine ScO2, concentrations of oxy- and deoxy- hemoglobin, and cytochrome aa3 redox state [713]. At present, the devices are based on continuous-wave or frequency-domain technology. Continuous-wave devices have been available for several years and monitor the intensity of the detected light relative to the emitted light; they describe oxygenation changes over time from an unknown base line [710]. Frequency-domain devices are a new technology and monitor intensity as well as phase-shift of the detected light relative to the emitted light; these devices can determine base line oxygenation as well as change over time [1113]. In this study, ScO2 was measured with a prototype frequency domain cerebral oximeter (NIM Incorporated, Philadelphia, PA) [14].

Cerebral oximetry and pulse-oximetry differ in several respects. Although both use near infrared light signals, pulse oximetry monitors the pulsatile signal component reflecting the arterial circulation, whereas cerebral oximetry monitors the nonpulsatile signal component reflecting the tissue circulation (arterioles, capillaries, venules). Cerebral oximetry views a "weighted average" of the tissue circulation, with approximately 85% of the signal originating from venules [11]. Because ScO2 is close to venous SO2, cerebral O2 extraction (CEO2) can be estimated from the difference of SaO2 and ScO2 (CEO2 = SaO2 - ScO2). Cerebral oximetry illuminates a "banana-shaped" tissue volume located about 2 cm beneath the optical probe; in young children (age < 7 years), the thin scalp and skull does not interfere [13].

Protocol
The optical probe was held on the forehead below the hairline. ScO2 was recorded over one minute while the subject was supine, quiet, and breathing spontaneously or by mechanical ventilation with room air or supplemental inspired O2, as indicated by the subject’s condition before the study. SaO2 (pulse oximetry) and arterial pressure were measured at the same time. Other data were recorded from the medical chart. In the CHD group, outcome was noted as "favorable" or "adverse" for 3 days postoperatively; the latter was defined by the occurrence of clinical seizures, stroke, coma, or death.

Data analysis
Data are presented as mean ± standard deviation. Comparisons between Control and CHD groups were made by analysis of variance (ANOVA) or Fisher’s exact test. When a significant overall F was found in ANOVA, pairwise multiple comparisons were made using Tukey’s test. Spearman’s correlation coefficient was calculated between ScO2 and demographic and physiologic variables. The relationship between ScO2 and the set of potential predictor variables (defined as those variables correlating with ScO2 at the less than or equal to 0.01 level of significance) was explored in a multivariable linear regression model using a forward stepwise variable selection method. When the R2 change was less than 0.05, the selection process was terminated. Fischer’s exact test compared favorable and adverse outcomes by preoperative ScO2. Statistical significance is p less than 0.05.


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
We enrolled 112 children, 93 in the CHD group and 19 in the Control group. The protocol was completed in 110 subjects; in 2 CHD subjects, neither cerebral or pulse oximetry could be performed (subjects were uncooperative). Table 1 displays the characteristics of the subjects completing the protocol. Of the 91 CHD subjects, 62% were male, 72% were white, and 62% were neonates (< 1 month) or infants (< 12 months). The Control and CHD groups differed in gender (p = 0.044) but not in race (p = 0.36) or age (p = 0.38).


View this table:
[in this window]
[in a new window]
 
Table 1. Subject Demographicsa

 
Table 2 lists the subjects’ cardiorespiratory status during the preoperative measurements. In the CHD group, 53% received inotropic agents and/or vasodilators, 12% were mechanically ventilated, and 13% received supplemental inspired O2. Two subjects (HLHS, pulmonary atresia) received a fentanyl infusion to facilitate mechanical ventilation. PDA subjects included 2 premature infants (< 37 weeks gestation). TGA subjects included 6 with intact ventricular septum and 4 with a VSD. The single ventricle with aortopulmonary shunt consisted of subjects born with HLHS that had a Norwood procedure (n = 8) 1 to 7 months earlier, or subjects born with tricuspid atresia that had a Blalock-Taussig shunt (n = 2) 13 and 29 months earlier. The single ventricle with bidirectional Glenn shunt included subjects born with HLHS (n = 8) or pulmonary atresia (n = 1) that had the shunt performed 6 to 30 months before study. Fontan subjects include those born with HLHS (n = 1) or pulmonary atresia (n = 2) that had the Fontan operation 8 to 34 months before study.


View this table:
[in this window]
[in a new window]
 
Table 2. Subjects’ Age and Cardiorespiratory Status During the Preoperative Measurements

 
Table 3 lists by diagnosis the SaO2, ScO2, and CEO2 of the subjects. As expected in many of the CHD diagnoses, SaO2 was less than control (all significant comparisons p < 0.0001). Many of the CHD subjects also exhibited lower ScO2, including PDA (p = 0.001), TOF (p = 0.018), HLHS (p < 0.0001), pulmonary atresia (p < 0.0001), and single ventricle with an aortopulmonary shunt (p < 0.0001) or bidirectional Glenn shunt (p < 0.0001). ScO2 in VSD, Fontan, and coarctation were similar to control (all comparisons, p > 0.20). Eight neonates and 5 infants had very low ScO2 [ie, < 38% (below 99% confidence interval for control group)]. These subjects included 2 HLHS (ScO2 27%, 35%), 2 TGA (ScO2 33%, 35%), 3 pulmonary atresia (ScO2 31%, 34%, 35%), 2 single ventricle with aortopulmonary shunt (ScO2 37%, 37%), 2 single ventricle with bidirectional Glen shunt (ScO2 36%, 37%), and one complex anatomic disease (35%). CEO2 in CHD and Control subjects were similar except for PDA and HLHS, in whom CEO2 was increased (p < 0.001 and p = 0.049, respectively).


View this table:
[in this window]
[in a new window]
 
Table 3. Arterial and Cerebral Oxygenation and Cerebral O2 Extraction

 
Table 4 displays the correlations between ScO2 and clinical variables for all subjects. Of the variables, the correlation with SaO2 was the greatest, followed by age and mean arterial pressure. Although SaO2 was directly related to ScO2 (Fig 1), its coefficient of determination was only fair (r2 = 0.4), indicating the predictive value of SaO2 for ScO2 was not good. No multivariable regression models predicted ScO2 any better than that by SaO2 alone (R = 0.63). ScO2 did not differ (p > 0.2) between subjects who did or did not receive inotropic agents, vasodilators, prostaglandin, or mechanical ventilation or by gender, race, or sedative regimen. A separate univariate analysis was performed for the Control group and the neonates with CHD. In the Control group, no significant correlations were found between ScO2 and clinical variables, nor did ScO2 differ by gender, age, race or sedative regimen (all p > 0.2). In the neonates with CHD, ScO2 was directly related to SaO2 (y = 0.49x + 7, r = 0.56, p < 0.0003). None of the other clinical variables correlated with ScO2, nor did ScO2 differ by gender or race (p > 0.2).


View this table:
[in this window]
[in a new window]
 
Table 4. Correlations With Cerebral O2 Saturation

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig 1. Relationship of arterial and cerebral O2 saturation in neonates, infants, and children with congenital heart disease (CHD). (n = 91.)

 
In the CHD group, postoperative outcome was "favorable" in 86 (94%) and "adverse" in 5 (6%). The adverse outcomes were seizures (n = 2) and death (n = 3) from cardiovascular failure. Of the 13 subjects with very low ScO2 (< 38%), adverse outcome occurred in 2 (18%). Of the 78 subjects who did not have a very low ScO2 (> 38%), adverse outcome occurred in 3 (3%). The difference in adverse outcome based on this preoperative ScO2 was not statistically significant (p = 0.12).


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Neurologic problems occur not uncommonly in CHD [13]. They may originate before, during, or after surgery, as a result of cerebral hypoxia, global ischemia, emboli, thrombosis, or genetic defects [36, 14, 15]. Our study shows that cerebral oxygenation is low in many patients with CHD, and very low in a few patients, which may represent cerebral hypoxia. Cerebral oxygenation correlated best with SaO2. Anatomic diagnosis also influenced it apart from SaO2, indicated by CEO2 in PDA and HLHS. However, the predictive value of SaO2 and other clinical factors for cerebral oxygenation was not good. With further work, cerebral oximetry might be used to identify cerebral hypoxia preoperatively, to guide ICU care and timing of surgery.

In the brain, the major source of tissue O2 content is the saturation of blood in the microcirculation. As a measure of this, ScO2 reflects brain tissue O2 content, which is influenced by cerebral O2 delivery, O2 consumption, and arterial/venous blood volume ratio. Because the latter does not differ among CHD lesions [11], the decreased ScO2 had to result from altered cerebral O2 delivery and/or O2 consumption. Cerebral O2 delivery is defined by SaO2, cerebral blood flow, and hemoglobin concentration. In our study, decreased SaO2 was one factor for decreased ScO2 in CHD. Hemoglobin concentration, sedation, cardiovascular drugs, mechanical ventilation, and neurologic injury were not factors, because the univariate analysis did not disclose an effect on ScO2, and subjects with preoperative neurologic injury were excluded from the study.

The critical ScO2 that results in cerebral hypoxic-ischemic damage is uncertain. Preliminary work suggests it occurs in the vicinity of 30% at normothermia, because this ScO2 is associated with decreased cerebral energy state, decreased EEG activity, and reduced cytochrome aa3; physiologic changes that inevitably lead to neuronal necrosis [18, 19]. We observed one neonate to have ScO2 below this threshold (incidence ~1%). This neonate was lethargic and hypotonic during the preoperative measurement, and had an adverse outcome postoperatively. However, it is possible for neurologic injury to occur following less severe cerebral hypoxia over a longer duration [20]. We observed 12 infants to have ScO2 between 31% and 38% (incidence 13%). One of these infants had an adverse outcome (seizures). However, our assessment of neurologic status (history and physical examination) during the preoperative measurement and postoperatively was not sensitive for neurologic injury. Further studies involving neurologic outcome and more sensitive methods to detect cerebral injury are required to define critical ScO2 and the value of the technology in this population.

In healthy pediatric and adult humans and animals, CEO2 is 25 to 40% [21, 22]. We observed most children with CHD to have CEO2 in this range, as have others [22]. Cerebral blood flow, hemoglobin-O2 binding affinity (P50), and cerebral metabolic rate influence CEO2. Noteworthy was the significantly increased CEO2 in HLHS and PDA. We believe that this reflects decreased cerebral blood flow as a result of diastolic "run-off." [23]

Neurologic problems in CHD are clearly multifactorial in origin. A large body of work has shown neurologic injury can occur from CPB and DHCA [15]. However, the correlation between neurologic injury and duration of CPB and DHCA is weak [1]. Moreover, in animal studies, brain damage does not occur until DHCA is prolonged (> 60 minutes), outside the range of customary clinical practice [16, 17]. These observations point to the important role of factors other than CPB or DHCA in neurologic injury.

Recent work suggests that many neurologic lesions predate surgery. These lesions may be congenital or acquired. McConnell and colleagues observed lesions preoperatively by MRI in 33% of infants, with 95% being acquired and 5% congenital [5]. The majority of acquired lesions were consistent with a global cerebral hypoxia-ischemic insult. In neonates after the arterial switch procedure, Bellinger and associates found that 23% had abnormalities on postoperative MRI, the lesions being acquired in 21% and congenital in 2% [1]. This study confirms the low incidence of congenital lesions, although the incidence of preoperatively acquired lesions was uncertain. However, acquired brain lesions were observed preoperatively by ultrasound in 15 to 20% of young infants with CHD [2, 6].

Neurobehavioral abnormalities also appear commonly before surgery in CHD. Limperopoulos and coworkers observed abnormal neurobehavioral tests in greater than one-half of infants before surgery [4] including hypotonia, hypertonia, altered consciousness, and feeding difficulties. Newberger and associates reported definite abnormalities on neurologic exam in 36% of TGA infants before surgery, a population with a low incidence (2%) of congenital brain lesions [3]. Similarly, Miller and colleagues described hypotonia in 43% of infants with CHD before surgery, well above the incidence of congenital brain malformations (5%) in their population [2]. Taken together, these studies indicate that many infants with CHD have or have had cerebral hypoxia-ischemia before surgery. Our results provide additional evidence to support this hypothesis.

Previous work used NIRS to describe changes in cerebral oxygenation during cardiac surgery. These studies found cerebral oxygenation to decrease during low flow CPB and DHCA, showing that certain phases of the surgical procedure incur a risk of cerebral hypoxic-ischemic injury [710]. In addition, CPB hematocrit and pH management was found to influence cerebral oxygenation, indicating that certain strategies might decrease the risk [8, 10]. However, base line cerebral oxygenation before surgery could not be determined with these NIRS instruments. Frequency-domain instruments, an advance in the technology, provide an opportunity to investigate risk before surgery.

Limitations of our study include time- and location sampling bias, as cerebral oxygenation was measured in only one region at one point in time. We attempted to reproduce the subject’s usual resting state at the time of the study. However, ScO2 (along with SaO2) may vary with time (activity). We examined the frontal neocortex, a region vulnerable to hypoxic-ischemic injury [5, 16], by placing the optical probe on the forehead. However, cerebral oxygenation may differ in another region, reflecting local disease (eg, thrombosis, embolus). Continuous monitoring in more than one location may increase detection of cerebral hypoxia.

Despite decreases in surgical mortality for CHD over the past few decades, neurologic sequelae continue to occur. Surgical factors such as CPB and DHCA have received much attention as contributing factors, and improvements in these techniques have decreased neurologic injury. Our findings add to the evidence suggesting that preoperative cerebral hypoxia-ischemia should now receive more attention.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
This study was supported in part by National Institutes of Health contract N44-NS-5-2314 and NIM Incorporated. The authors thank Paul Gallagher for statistical consultation and Hilary Kleine for help conducting the study.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Bellinger D.C., Jonas R.A., Rappaport L.A., et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 1995;332:549-555.[Abstract/Free Full Text]
  2. Miller G., Eggli K.D., Contant C., et al. Postoperative neurologic complications after open-heart surgery on young infants. Arch Pediatr Adol Med 1995;149:764-768.[Abstract/Free Full Text]
  3. Newburger J.W., Jonas R.A., Wernovsky G., et al. A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J Med 1993;329:1057-1064.[Abstract/Free Full Text]
  4. Limperopoulos C., Majnemer A., Shevell M.I., et al. Neurologic status of newborns with congenital heart defects before open heart surgery. Pediatr 1999;103:402-408.[Abstract/Free Full Text]
  5. McConnell J.R., Fleming W.H., Chu W.-K., et al. Magnetic resonance imaging of the brain in infants and children before and after cardiac surgery. Am J Dis Child 1990;144:374-378.[Abstract/Free Full Text]
  6. Van Houten J.P., Rothman A., Bejar R. High incidence of cranial ultrasound abnormalities in full-term infants with CHD. Am J Perinat 1996;13:47-53.[Medline]
  7. Kurth C.D., Steven J.M., Nicolson S.C. Cerebral oxygenation during pediatric cardiac surgery using deep hypothermic circulatory arrest. Anesthesiology 1995;82:74-82.[Medline]
  8. Kurth C.D., Steven J.M., Nicolson S.C., Jacobs M.L. Cerebral oxygenation during cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 1997;113:71-79.[Abstract/Free Full Text]
  9. Du Plessis A.J., Newburger J., Jonas R.A., et al. Cerebral oxygen supply and utilization during infant cardiac surgery. Ann Neurol 1995;37:488-497.[Medline]
  10. Du Plessis A.J., Jonas R.A., Wypij D., et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 1995;109:959-975.[Abstract]
  11. Watzman H.M., Kurth C.D., Montenegro L.M., et al. Arterial and venous contributions to near infrared cerebral oximetry. Anesthesiology 2000;93:947-953.[Medline]
  12. Benaron D.A., Kurth C.D., Steven J.M., et al. Transcranial optical path length in infants by near-infrared phase-shift spectroscopy. J Clin Monit 1995;11:109-117.[Medline]
  13. Kurth C.D., Thayer W.S. A multiwavelength frequency-domain near infrared cerebral oximeter. Phys Med Biol 1999;44:727-740.[Medline]
  14. Newburger J.W., Silbert A.R., Buckley L.P., Fyler D.C. Cognitive function and age at repair of transposition of the great arteries in children. N Engl J Med 1984;310:1495-1499.[Abstract]
  15. Jonas R.A. Hypothermia, circulatory arrest, and the pediatric brain. J Cardiothor Vasc Anesth 1996;10:66-74.[Medline]
  16. Kurth C.D., Priestley M., Golden J., et al. Regional patterns of neuronal death after deep hypothermic circulatory arrest in newborn pigs. J Thorac Cardiovasc Surg 1999;118:1068-1077.[Abstract/Free Full Text]
  17. Mezrow C.K., Gandsas A., Sadeghi A.M., et al. Metabolic correlates of neurologic and behavioral injury after prolonged hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1995;109:959-975.
  18. Nioka S., Chance B., Smith D.S., et al. Cerebral energy metabolism and oxygen state during hypoxia in neonate, and adult dogs. Pediatr Res 1990;28:54-61.[Medline]
  19. Springett R., Newman J., Cope M., Delpy D.T. Oxygen dependency and precision of cytochrome oxidase signal from full spectrum NIRS of the piglet brain. Am J Physiol Heart Circ Physiol 2000;279:H2202-H2209.[Abstract/Free Full Text]
  20. MacManus J.P., Linnik M.D. Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cerebral Blood Flow Metab 1997;17:815-832.[Medline]
  21. Oja J.M.E., Gillen J.S., Kauppinen R.A., et al. Determination of oxygen extraction ratios by magnetic resonance imaging. J Cerebral Blood Flow Metabol 1999;19:1289-1295.[Medline]
  22. Pesonen E.J., Peltola K.I., Korpela R.E., et al. Delayed impairment of cerebral oxygenation after deep hypothermic circulatory arrest in children. Ann Thorac Surg 1999;67:1765-1770.[Abstract/Free Full Text]
  23. Kirshbom P.M., Skaryak L.A., DiBernardo L.R., et al. Effects of aortopulmonary collaterals on cerebral cooling and cerebral metabolic recovery after circulatory arrest. Circulation 1995;92:490-494.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
B. D. Kussman, D. Wypij, J. A. DiNardo, J. W. Newburger, J. E. Mayer Jr, P. J. del Nido, E. A. Bacha, F. Pigula, E. McGrath, P. C. Laussen, et al.
Cerebral Oximetry During Infant Cardiac Surgery: Evaluation and Relationship to Early Postoperative Outcome
Anesth. Analg., April 1, 2009; 108(4): 1122 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. D. Kurth, J. C. McCann, J. Wu, L. Miles, and A. W. Loepke
Cerebral Oxygen Saturation-Time Threshold for Hypoxic-Ischemic Injury in Piglets
Anesth. Analg., April 1, 2009; 108(4): 1268 - 1277.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. W. Fischer and M. E. Stone
Cerebral Air Embolism Recognized by Cerebral Oximetry
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2009; 13(1): 56 - 59.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. C. Hirsch, J. R. Charpie, R. G. Ohye, and J. G. Gurney
Near-infrared spectroscopy: What we know and what we need to know--A systematic review of the congenital heart disease literature
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 154 - 159.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. D. Tobias
Cerebral Oximetry Monitoring with Near Infrared Spectroscopy Detects Alterations in Oxygenation Before Pulse Oximetry
J Intensive Care Med, November 1, 2008; 23(6): 384 - 388.
[Abstract] [PDF]


Home page
J Intensive Care MedHome page
J. D. Tobias
Cerebral Oximetry Using Near-Infrared Spectroscopy Aids in the Diagnosis of Interrupted Aortic Arch
J Intensive Care Med, September 1, 2008; 23(5): 335 - 337.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. W. Fischer
Recent Advances in Application of Cerebral Oximetry in Adult Cardiovascular Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 60 - 69.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Li, G. Zhang, H. Holtby, A.-M. Guerguerian, S. Cai, T. Humpl, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell
The influence of systemic hemodynamics and oxygen transport on cerebral oxygen saturation in neonates after the Norwood procedure
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 83 - 90.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Denault, A. Deschamps, and J. M. Murkin
A Proposed Algorithm for the Intraoperative Use of Cerebral Near-Infrared Spectroscopy
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 274 - 281.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. N. Fenton, K. Lessman, K. Glogowski, S. Fogg, and K. F. Duncan
Cerebral Oxygen Saturation Does Not Normalize Until After Stage 2 Single Ventricle Palliation
Ann. Thorac. Surg., April 1, 2007; 83(4): 1431 - 1436.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. D. Williams and C. Ramamoorthy
Brain monitoring and protection during pediatric cardiac surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 23 - 33.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. D. Kussman, K. Gauvreau, J. A. DiNardo, J. W. Newburger, A. S. Mackie, K. L. Booth, P. J. del Nido, S. J. Roth, and P. C. Laussen
Cerebral perfusion and oxygenation after the Norwood procedure: Comparison of right ventricle-pulmonary artery conduit with modified Blalock-Taussig shunt
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. D. Tobias
Cerebral Oximetry Monitoring Provides Early Warning of Hypercyanotic Spells in an Infant with Tetralogy of Fallot
J Intensive Care Med, March 1, 2007; 22(2): 118 - 120.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ricci, P. Lombardi, S. Schultz, A. Galindo, E. Coscarella, A. Vasquez, and E. Rosenkranz
Near-infrared spectroscopy to monitor cerebral oxygen saturation in single-ventricle physiology
J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. L. Dent, J. P. Spaeth, B. V. Jones, S. M. Schwartz, T. A. Glauser, B. Hallinan, J. M. Pearl, P. R. Khoury, and C. D. Kurth
Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 190 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. L. Dent, J. P. Spaeth, B. V. Jones, S. M. Schwartz, T. A. Glauser, B. Hallinan, J. M. Pearl, P. R. Khoury, and C. D. Kurth
Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion
J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1523 - 1530.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. W. Gaynor, S. C. Nicolson, G. P. Jarvik, G. Wernovsky, L. M. Montenegro, N. B. Burnham, D. M. Hartman, A. Louie, T. L. Spray, and R. R. Clancy
Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1278 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. D. Kussman, D. Wypij, J. A. DiNardo, J. Newburger, R. A. Jonas, J. Bartlett, E. McGrath, and P. C. Laussen
An Evaluation of Bilateral Monitoring of Cerebral Oxygen Saturation During Pediatric Cardiac Surgery
Anesth. Analg., November 1, 2005; 101(5): 1294 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. B. Andropoulos, S. A. Stayer, L. K. Diaz, and C. Ramamoorthy
Neurological Monitoring for Congenital Heart Surgery
Anesth. Analg., November 1, 2004; 99(5): 1365 - 1375.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
C. L Cua, T. M Hoffman, R. Taeed, S. Weinstein, D. Gomez, V. F Olshove, and J. M Craenen
Cerebral saturations trend with mixed venous saturations in patients undergoing extracorporeal life support
Perfusion, May 1, 2004; 19(3): 171 - 176.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. M. Hoffman, E. A. Stuth, R. D. Jaquiss, P. L. Vanderwal, S. R. Staudt, T. J. Troshynski, N. S. Ghanayem, and J. S. Tweddell
Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion
J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 223 - 233.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Choe, T. Durduran, G. Yu, M. J. M. Nijland, B. Chance, A. G. Yodh, and N. Ramanujam
Transabdominal near infrared oximetry of hypoxic stress in fetal sheep brain in utero
PNAS, October 28, 2003; 100(22): 12950 - 12954.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. B. Andropoulos, S. A. Stayer, E. D. McKenzie, and C. D. Fraser Jr
Novel cerebral physiologic monitoring to guide low-flow cerebral perfusion during neonatal aortic arch reconstruction
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. T. Mahle, F. Tavani, R. A. Zimmerman, S. C. Nicolson, K. K. Galli, J. W. Gaynor, R. R. Clancy, L. M. Montenegro, T. L. Spray, R. M. Chiavacci, et al.
An MRI Study of Neurological Injury Before and After Congenital Heart Surgery
Circulation, September 24, 2002; 106(12_suppl_1): I-109 - I-114.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas L. Spray
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurth, C. D.
Right arrow Articles by Nicolson, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurth, C. D.
Right arrow Articles by Nicolson, S. C.
Related Collections
Right arrow Congenital - cyanotic


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS